Text Registration
Copyright Title
IL-22 and IL-17 and Immune Responses in the Female Genital Tract
Status
Published
on 8 Oct 2015
Year of Creation
2015
Copyright Claimant
Hadijat-Kubura Moradeke Makinde
Registration Number
TX0008103369
on 8 Oct 2015Copyright Summary
The U.S. Copyright record (Registration Number: TX0008103369) dated 8 Oct 2015, pertains to an electronic file (eService) titled "IL-22 and IL-17 and Immune Responses in the Female Genital Tract" created in 2015. The copyright holder is Hadijat-Kubura Moradeke Makinde, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Hadijat-Kubura Moradeke Makinde.
Application Details
Registration Number
TX0008103369
Registration Date
10/8/2015
Year of Creation
2015
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Diana G Zajic, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600 xext77020, disspub@proquest.com
Statements
Application Title Statement: IL-22 and IL-17 and Immune Responses in the Female Genital Tract
Author Statement: Hadijat-Kubura Moradeke Makinde Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.